Chemo-free BRCA-targeted Neoadjuvant Strategy

Clinical trial NCT05209529 · WITHDRAWN

Trial details

NCT number: NCT05209529
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

TNBC - Triple-Negative Breast Cancer BRCA1 Mutation BRCA2 Mutation

Start date: 2024-02-01
Primary completion: 2028-09-06
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.